HOPELESSNESS AND SUICIDAL IDEATION IN OUTPATIENTS WITH TREATMENT-RESISTANT DEPRESSION: PREVALENCE AND IMPACT ON TREATMENT OUTCOME
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Depression and hopelessness are risk factors for suicide. The purpose of this study was to examine the extent of suicidal ideation and hopelessness in outpatients with treatment-resistant depression (TRD) and to study the impact of suicidal ideation and hopelessness on treatment with nortriptyline (NT). The degree of suicidal ideation and hopelessness was assessed during the screen visit with the use of items #3 and #30 of the Hamilton Depression Rating Scale (HAM-D) in 89 patients with TRD who entered a 6-week open trial of NT. Forty of these patients also completed the Beck Hopelessness Index (BHI) during the screen visit. In separate logistic regressions, the scores from the BHI and the two HAM-D items were then tested as predictors of clinical response to the 6-week trial with NT, controlling for the severity of depression. More than half of patients reported thoughts or wishes of death to self and significant hopelessness. A greater degree of hopelessness before treatment in completers, reflected by the score on the HAM-D item #30, predicted response to NT. More than half of patients with prominent hopelessness who completed the trial responded. Patients with TRD are more likely than not to report prominent suicidal ideation and hopelessness. Furthermore, a full 6-week trial of NT, a relatively noradrenergic tricyclic antidepressant, may be particularly useful in patients who have failed to respond to several antidepressants and also report significant hopelessness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Affective disorders and suicide risk: a reexamination
Bostwick, J. M., & Pankratz, V. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1925 · Cited by 878 · cited 2×
“Overall, the lifetime risk for suicide in depressed patients has been estimated at 2.2% (Bostwick and Pankratz, 2000).”
BackgroundInfluentialDEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
Self-citation(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.8.997 · Cited by 580
Shaffer, D., & Pfeffer, C. R. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107001-00003 · Cited by 460
Prediction of eventual suicide in psychiatric inpatients by clinical ratings of hopelessness
Beck, A. T., Brown, G., & Steer, R. A. (1989) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.57.2.309 · Cited by 448 · cited 1×
“Both depression (Bostwick and Pankratz, 2000) and hopelessness (Beck et al., 1989) are risk factors for suicidal ideation and suicide.”
BackgroundSuicidal ideation and health‐related quality of life in the community
Goldney, R. D., Fisher, L. J., Wilson, D. H., & Cheok, F. (2001) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2001.tb143717.x · Cited by 96
Cited by
A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
Mrazek, D. A., Hornberger, J. C., Altar, C. A., & Degtiar, I. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300059 · Cited by 580
The Psychology and Neurobiology of Suicidal Behavior
Joiner, T. E., Brown, J. S., & Wingate, L. R. (2005) · Annual Review of Psychology · doi:10.1146/annurev.psych.56.091103.070320 · Cited by 481
Treatment-resistant depression and suicidality
Bergfeld, I. O., Mantione, M., Figee, M., Schuurman, P. R., Lok, A., & Denys, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.016 · Cited by 256
Perlis, R. H., Iosifescu, D. V., Castro, V. M., Murphy, S. N., Gainer, V. S., Minnier, J., Cai, T., Goryachev, S., Zeng, Q., Gallagher, P. J., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711000997 · Cited by 193
“…respond to at least two adequate trials of medication or other somatic therapies (Fava & Rush, 2006 ; Rush et al. 2006), contributes substantially to the disability and associated costs of MDD (Gibson et al. 2010) and may also be associated with elevated risk for suicide (Papakostas et al. 2003).”
BackgroundTwo-year outcome of vagus nerve stimulation in treatment-resistant depression
Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db8831 · Cited by 178
Metadata
- Authors
- PAPAKOSTAS, G. I., PETERSEN, T., PAVA, J., MASSON, E., WORTHINGTON, J. J., ALPERT, J. E., FAVA, M., & NIERENBERG, A. A.
- Venue
- The Journal of Nervous and Mental Disease
- Published
- 2003-07
- Volume
- 191
- Issue
- 7
- Pages
- 444-449
- ISSN
- 0022-3018 (ISSN-L)
- OpenAlex
- W1971174436
- Cited by
- 69
- References
- 6
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HOPELESSNESS AND SUICIDAL IDEATION IN OUTPATIENTS WITH TREATMENT-RESISTANT DEPRESSION: PREVALENCE AND IMPACT ON TREATMENT OUTCOME. https://app.cochat.ai/papers/10.1097/01.nmd.0000081591.46444.97
- The paper
- PAPAKOSTAS, G. I., PETERSEN, T., PAVA, J., MASSON, E., WORTHINGTON, J. J., ALPERT, J. E., FAVA, M., & NIERENBERG, A. A. (2003). HOPELESSNESS AND SUICIDAL IDEATION IN OUTPATIENTS WITH TREATMENT-RESISTANT DEPRESSION: PREVALENCE AND IMPACT ON TREATMENT OUTCOME. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/01.nmd.0000081591.46444.97
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.